The distribution of CNV percentages across different cancer types is shown in Supplementary Fig. 7A. We observed that the CNV of PRKCSH was particularly high in patients with ACC, SARC, OV, LUSC, ESCA, UCS, LUAD, and TGCT. Here, PRKCSH is linked to cancer.